MoneyWorks4Me

The Revenue for the quarter ended  March 2024 of Rs. 213.31 millions grew by 17.51 % from Rs. 181.52 millions.The Net Profit of the company reported a remarkable increase of 134.65% to Rs. 39.28  millions  from Rs. 16.74 millions in previous same quarter.Operating Profit saw a handsome growth to 50.61 millions from 28.63 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 213.31 181.52 17.51 667.99 650.98 2.61 667.99 650.98 2.61
Other Income 19.67 15.92 23.56 43.02 34.04 26.38 43.02 34.04 26.38
PBIDT 50.61 28.63 76.77 167.21 79.87 109.35 167.21 79.87 109.35
Interest 2.53 5.09 -50.29 11.56 12.31 -6.09 11.56 12.31 -6.09
PBDT 48.08 23.54 104.25 155.65 67.56 130.39 155.65 67.56 130.39
Depreciation 2.03 1.98 2.53 8.10 7.44 8.87 8.10 7.44 8.87
PBT 46.05 21.56 113.59 147.55 60.12 145.43 147.55 60.12 145.43
TAX 6.77 4.82 40.46 29.57 14.52 103.65 29.57 14.52 103.65
Deferred Tax -0.93 -1.41 -34.04 -0.93 -1.41 -34.04 -0.93 -1.41 -34.04
PAT 39.28 16.74 134.65 117.98 45.60 158.73 117.98 45.60 158.73
Equity 227.45 176.64 28.76 227.45 176.64 28.76 227.45 176.64 28.76
PBIDTM(%) 23.73 15.77 50.43 25.03 12.27 104.02 25.03 12.27 104.02
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..